Taken together these data demonstrate a central role of HPA axis dysregulation and high levels of GC both in MDD and AD etiology and suggest the possibility that GR might be suitable targets both for antidepressant and antidementia drugs. This evidence concerns the gene NR3C1 and major depressive disorder.